BRTX
BioRestorative Therapies IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$8.98M
P/E Ratio
—
EPS
$-1.06
Beta
0.20
52W High
$1.89
52W Low
$0.16
50-Day MA
$0.27
200-Day MA
$0.88
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
0.00
About BioRestorative Therapies Inc
BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols that primarily involve adult stem cells. The company is headquartered in Melville, New York.
Fundamentals
| Revenue (TTM) | 357,870 |
| Gross Profit (TTM) | 329,550 |
| EBITDA | $-14.01M |
| Operating Margin | -14613.00% |
| Return on Equity | -241.10% |
| Return on Assets | -118.80% |
| Revenue/Share (TTM) | $0.03 |
| Book Value | $0.12 |
| Price-to-Book | 3.07 |
| Price-to-Sales (TTM) | 25.10 |
| EV/Revenue | 1.054 |
| EV/EBITDA | 0.13 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -7.30% |
| Shares Outstanding | $25.48M |
| Float | $24.18M |
| % Insiders | 12.13% |
| % Institutions | 7.26% |
Historical Volatility
HV 10-Day
132.37%
HV 20-Day
122.32%
HV 30-Day
106.02%
HV 60-Day
118.01%
HV Rank
—
Volatility is currently expanding
More HEALTHCARE Stocks
Data last updated: 6/13/2026